发明申请
US20100197665A1 INDAZOLE DERIVATIVES AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER
有权
用作治疗癌症的激酶抑制剂的吲哚衍生物
- 专利标题: INDAZOLE DERIVATIVES AS KINASE INHIBITORS FOR THE TREATMENT OF CANCER
- 专利标题(中): 用作治疗癌症的激酶抑制剂的吲哚衍生物
-
申请号: US12520387申请日: 2007-12-14
-
公开(公告)号: US20100197665A1公开(公告)日: 2010-08-05
- 发明人: Tiziano Bandiera , Andrea Lombardi Borgia , Marcella Nesi , Ettore Perrone , Roberto Bossi , Paolo Polucci
- 申请人: Tiziano Bandiera , Andrea Lombardi Borgia , Marcella Nesi , Ettore Perrone , Roberto Bossi , Paolo Polucci
- 申请人地址: IT Nerviano (MI)
- 专利权人: NERVIANO MEDICAL SCIENCES S.R.L.
- 当前专利权人: NERVIANO MEDICAL SCIENCES S.R.L.
- 当前专利权人地址: IT Nerviano (MI)
- 优先权: EP06126701.9 20061220
- 国际申请: PCT/EP2007/063998 WO 20071214
- 主分类号: A61K31/551
- IPC分类号: A61K31/551 ; C07D231/56 ; A61K31/416 ; C07D403/12 ; A61K31/496 ; C07D211/06 ; A61K31/454 ; C07D243/08 ; C07D413/14 ; A61K31/5377 ; C07D405/14 ; A61K31/4439 ; A61P35/00 ; A61P11/00 ; A61P19/02
摘要:
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a dysregulated protein kinase activity, like cancer formula (I).
公开/授权文献
信息查询